When nature’s robots go rogue: exploring protein homeostasis dysfunction and the implications for understanding human aging disease pathologies

References

• Squier TC. Oxidative stress and protein aggregation during biological aging. Exp Gerontol. 2001;36(9):1539–1550.
   PubMed Web of Science ®Google Scholar
• Niccoli T, Partridge L. Ageing as a risk factor for disease. Curr Biol. 2012;22(17):R741–R752.
   PubMed Web of Science ®Google Scholar
• Wilson PW, D’Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–1847.
   PubMed Web of Science ®Google Scholar
• Mariani E, Polidori M, Cherubini A, et al. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chrom B. 2005;827(1):65–75.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Rodero S, Jl F-M, Menéndez-Torre E, et al. Aging genetics and aging. Aging Dis. 2011;2(3):186.
   PubMed Web of Science ®Google Scholar
• Powers ET, Morimoto RI, Dillin A, et al. Biological and chemical approaches to diseases of proteostasis deficiency. Ann Rev Biochem. 2009;78:959–991.
   PubMed Web of Science ®Google Scholar
• Hartl FU, Bracher A, Hayer-Hartl M. Molecular chaperones in protein folding and proteostasis. Nature. 2011;475(7356):324–332.
   PubMed Web of Science ®Google Scholar
• Shaw AC, Joshi S, Greenwood H, et al. Aging of the innate immune system. Curr Opin Immunol. 2010;22(4):507–513.
   PubMed Web of Science ®Google Scholar
• Talens RP, Christensen K, Putter H, et al. Epigenetic variation during the adult lifespan: cross‐sectional and longitudinal data on monozygotic twin pairs. Aging Cell. 2012;11(4):694–703.
   PubMed Web of Science ®Google Scholar
• Moskalev AA, Shaposhnikov MV, Plyusnina EN, et al. The role of DNA damage and repair in aging through the prism of Koch-like criteria. Ageing Res Rev. 2013;12(2):661–684.
   PubMed Web of Science ®Google Scholar
• Burtner CR, Kennedy BK. Progeria syndromes and ageing: what is the connection? Nat Rev Mol Cell Biol. 2010;11(8):567–578.
   PubMed Web of Science ®Google Scholar
• Hoeijmakers JH. DNA damage, aging, and cancer. New Eng J Med. 2009;361(15):1475–1485.
   PubMed Web of Science ®Google Scholar
• Green DR, Galluzzi L, Kroemer G. Mitochondria and the autophagy–inflammation–cell death axis in organismal aging. Science. 2011;333(6046):1109–1112.
   PubMed Web of Science ®Google Scholar
• Harman D. The free radical theory of aging: effect of age on serum copper levels. J Gerontol. 1965;20(2):151–153.
   PubMedGoogle Scholar
• López-Otín C, Blasco MA, Partridge L, et al. The hallmarks of aging. Cell. 2013;153(6):1194–1217.
   PubMed Web of Science ®Google Scholar
• Sastre J, Pallardo FV, Garcia de la Asuncion J, et al. Mitochondria, oxidative stress and aging. Free Radic Res. 2000;32(3):189–198.
   PubMed Web of Science ®Google Scholar
• Dai D-F, Chiao YA, Marcinek DJ, et al. Mitochondrial oxidative stress in aging and healthspan. Longev Healthspan. 2014;3:6.
   PubMedGoogle Scholar
• D’Alessandro A, El Kasmi KC, Plecita-Hlavata L, et al. Hallmarks of pulmonary hypertension: mesenchymal and inflammatory cell metabolic reprogramming. Antioxid Redox Signal. 2018;28(3):230–250.
   Google Scholar
• Reisz JA, Bansal N, Qian J, et al. Effects of ionizing radiation on biological molecules: mechanisms of damage and emerging methods of detection. Antioxid Redox Signal. 2014;21(2):260–292.
   PubMed Web of Science ®Google Scholar
• Ott C, Grune T. Protein oxidation and proteolytic signalling in aging. Curr Pharm Des. 2014;20(18):3040–3051.
   PubMed Web of Science ®Google Scholar
• Srivastava S. The mitochondrial basis of aging and age-related disorders. Genes (Basel). 2017;8:12.
   Web of Science ®Google Scholar
• Youle RJ, Narendra DP. Mechanisms of mitophagy. Nat Rev Mol Cell Biol. 2011;12(1):9–14.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Zheng Y, Zhang X, et al. BNIP3L/NIX-mediated mitophagy protects against ischemic brain injury independent of PARK2. Autophagy. 2017;13(10):1754–1766.
   PubMed Web of Science ®Google Scholar
• Bruick RK. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci USA. 2000;97(16):9082–9087.
   PubMed Web of Science ®Google Scholar
• Lee H, Paik SG. Regulation of BNIP3 in normal and cancer cells. Mol Cells. 2006;21(1):1–6.
   PubMed Web of Science ®Google Scholar
• Greene AW, Grenier K, Aguileta MA, et al. Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment. EMBO Rep. 2012;13(4):378–385.
   PubMed Web of Science ®Google Scholar
• Lin W, Kang UJ. Characterization of PINK1 processing, stability, and subcellular localization. J Neurochem. 2008;106(1):464–474.
   PubMed Web of Science ®Google Scholar
• Jin SM, Lazarou M, Wang C, et al. Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J Cell Biol. 2010;191(5):933–942.
   PubMed Web of Science ®Google Scholar
• Park J, Lee SB, Lee S, et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature. 2006;441(7097):1157–1161.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhang C, Zhao Y, et al. Parkin targets HIF-1alpha for ubiquitination and degradation to inhibit breast tumor progression. Nat Commun. 2017;8(1):1823.
   PubMedGoogle Scholar
• Popa-Wagner A, Sandu RE, Cristin C, et al. Increased degradation rates in the components of the mitochondrial oxidative phosphorylation chain in the cerebellum of old mice. Front Aging Neurosci. 2018;10:32.
   PubMed Web of Science ®Google Scholar
• Drake JC, Yan Z. Mitophagy in maintaining skeletal muscle mitochondrial proteostasis and metabolic health with ageing. J Physiol. 2017;595(20):6391–6399.
   PubMed Web of Science ®Google Scholar
• Lee JJ, Sanchez-Martinez A, Zarate AM, et al. Basal mitophagy is widespread in Drosophila but minimally affected by loss of Pink1 or parkin. J Cell Biol. 2018.
   Google Scholar
• McWilliams TG, Prescott AR, Montava-Garriga L, et al. Basal mitophagy occurs independently of PINK1 in mouse tissues of high metabolic demand. Cell Metab. 2018;27(2):439–449.e435.
   PubMed Web of Science ®Google Scholar
• Oh CK, Sultan A, Platzer J, et al. S-Nitrosylation of PINK1 attenuates PINK1/parkin-dependent mitophagy in hiPSC-based Parkinson’s disease models. Cell Rep. 2017;21(8):2171–2182.
   PubMed Web of Science ®Google Scholar
• Nemkov T, Sun K, Reisz JA, et al. Hypoxia modulates the purine salvage pathway and decreases red blood cell and supernatant levels of hypoxanthine during refrigerated storage. Haematologica. 2018;103(2):361–372.
   Google Scholar
• Lecker SH, Goldberg AL, Mitch WE. Protein degradation by the ubiquitin–proteasome pathway in normal and disease states. J Am Soc Nephrol. 2006;17(7):1807–1819.
   PubMed Web of Science ®Google Scholar
• Hatle KM, Gummadidala P, Navasa N, et al. MCJ/DnaJC15, an endogenous mitochondrial repressor of the respiratory chain that controls metabolic alterations. Mol Cell Biol. 2013;33(11):2302–2314.
   PubMed Web of Science ®Google Scholar
• Champagne DP, Hatle KM, Fortner KA, et al. Fine-tuning of CD8(+) T cell mitochondrial metabolism by the respiratory chain repressor MCJ dictates protection to influenza virus. Immunity. 2016;44(6):1299–1311.
   PubMed Web of Science ®Google Scholar
• Milenkovic D, Blaza JN, Larsson N-G, et al. The enigma of the respiratory chain supercomplex. Cell Metab. 2017;25(4):765–776.
   PubMed Web of Science ®Google Scholar
• Hadizadeh Esfahani A, Sverchkova A, Saez-Rodriguez J, et al. A systematic atlas of chaperome deregulation topologies across the human cancer landscape. PLoS Comput Biol. 2018;14(1):e1005890.
   PubMed Web of Science ®Google Scholar
• Dayalan Naidu S, Dinkova-Kostova AT. Regulation of the mammalian heat shock factor 1. Febs J. 2017;284(11):1606–1627.
   PubMed Web of Science ®Google Scholar
• Solis EJ, Pandey JP, Zheng X, et al. Defining the essential function of yeast Hsf1 reveals a compact transcriptional program for maintaining eukaryotic proteostasis. Mol Cell. 2016;63(1):60–71.
   PubMed Web of Science ®Google Scholar
• D’Alessandro A, Righetti PG, Zolla L. The red blood cell proteome and interactome: an update. J Proteome Res. 2010;9(1):144–163.
   PubMed Web of Science ®Google Scholar
• Kalmar B, Greensmith L. Section I: heat shock proteins and neurodegenerative diseases. In: Brown IR, Editor. Heat shock proteins and the brain: implications for neurodegenerative diseases and neuroprotection. Dordrecht: Springer; 2008.
   Google Scholar
• Carreras-Sureda A, Pihan P, Hetz C. Calcium signaling at the endoplasmic reticulum: fine-tuning stress responses. Cell Calcium. 2018;70:24-31.
   Google Scholar
• Chevet E, Hetz C, Samali A. Endoplasmic reticulum stress-activated cell reprogramming in oncogenesis. Cancer Discov. 2015;5(6):586–597.
   PubMed Web of Science ®Google Scholar
• Kalies KU, Allan S, Sergeyenko T, et al. The protein translocation channel binds proteasomes to the endoplasmic reticulum membrane. Embo J. 2005;24(13):2284–2293.
   PubMed Web of Science ®Google Scholar
• Calfon M, Zeng H, Urano F, et al. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature. 2002;415(6867):92–96.
   PubMed Web of Science ®Google Scholar
• Gething MJ, Sambrook J. Protein folding in the cell. Nature. 1992;355(6355):33–45.
   PubMed Web of Science ®Google Scholar
• Schuck S, Prinz WA, Thorn KS, et al. Membrane expansion alleviates endoplasmic reticulum stress independently of the unfolded protein response. J Cell Biol. 2009;187(4):525–536.
   PubMed Web of Science ®Google Scholar
• Wang M, Kaufman RJ. Protein misfolding in the endoplasmic reticulum as a conduit to human disease. Nature. 2016;529(7586):326–335.
   PubMed Web of Science ®Google Scholar
• Frakes AE, Dillin A. The UPRER: sensor and coordinator of organismal homeostasis. Mol Cell. 2017;66(6):761–771.
   PubMed Web of Science ®Google Scholar
• Kristensen CM, Brandt CT, Ringholm S, et al. PGC-1alpha in aging and lifelong exercise training-mediated regulation of UPR in mouse liver. Exp Gerontol. 2017;98:124–133.
   PubMed Web of Science ®Google Scholar
• Han J, Kaufman RJ. Measurement of the unfolded protein response to investigate its role in adipogenesis and obesity. Methods Enzymol. 2014;538:135–150.
   PubMed Web of Science ®Google Scholar
• van der Bliek AM, Sedensky MM, Morgan PG. Cell biology of the mitochondrion. Genetics. 2017;207(3):843–871.
   PubMed Web of Science ®Google Scholar
• Davies KJ. Degradation of oxidized proteins by the 20S proteasome. Biochimie. 2001;83(3–4):301–310.
   PubMed Web of Science ®Google Scholar
• Gupta I, Singh K, Varshney NK, et al. Delineating crosstalk mechanisms of the ubiquitin proteasome system that regulate apoptosis. Front Cell Dev Biol. 2018;6:11.
   PubMedGoogle Scholar
• Choi J, Baek KH. Cellular functions of stem cell factors mediated by the ubiquitin-proteasome system. Cell Mol Life Sci. 2018.
   PubMedGoogle Scholar
• Saez I, Koyuncu S, Gutierrez-Garcia R, et al. Insights into the ubiquitin-proteasome system of human embryonic stem cells. Sci Rep. 2018;8(1):4092.
   PubMedGoogle Scholar
• Catarino S, Pereira P, Girao H. Molecular control of chaperone-mediated autophagy. Essays Biochem. 2017;61(6):663–674.
   PubMed Web of Science ®Google Scholar
• Xu H, Ren D. Lysosomal physiology. Annu Rev Physiol. 2015;77:57–80.
   PubMed Web of Science ®Google Scholar
• Boya P, Codogno P, Rodriguez-Muela N. Autophagy in stem cells: repair, remodelling and metabolic reprogramming. Development. 2018;145:4.
   Web of Science ®Google Scholar
• Pietrocola F, Izzo V, Niso-Santano M, et al. Regulation of autophagy by stress-responsive transcription factors. Semin Cancer Biol. 2013;23(5):310–322.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Pietrocola F, Levine B, et al. Metabolic control of autophagy. Cell. 2014;159(6):1263–1276.
   PubMed Web of Science ®Google Scholar
• Kaur J, Debnath J. Autophagy at the crossroads of catabolism and anabolism. Nat Rev Mol Cell Biol. 2015;16(8):461–472.
   PubMed Web of Science ®Google Scholar
• Rubinsztein DC, Marino G, Kroemer G. Autophagy and aging. Cell. 2011;146(5):682–695.
   PubMed Web of Science ®Google Scholar
• Rybstein MD, Bravo-San Pedro JM, Kroemer G, et al. The autophagic network and cancer. Nat Cell Biol. 2018;20(3):243–251.
   PubMed Web of Science ®Google Scholar
• Labbadia J, Morimoto RI. Repression of the heat shock response is a programmed event at the onset of reproduction. Mol Cell. 2015;59(4):639–650.
   PubMed Web of Science ®Google Scholar
• Zhang S, Eitan E, Mattson MP. Early involvement of lysosome dysfunction in the degeneration of cerebral cortical neurons caused by the lipid peroxidation product 4-hydroxynonenal. J Neurochem. 2017;140(6):941–954.
   PubMed Web of Science ®Google Scholar
• Hohn A, Jung T, Grimm S, et al. Lipofuscin inhibits the proteasome by binding to surface motifs. Free Radic Biol Med. 2011;50(5):585–591.
   PubMed Web of Science ®Google Scholar
• Cuervo AM, Dice JF. Age-related decline in chaperone-mediated autophagy. J Biol Chem. 2000;275(40):31505–31513.
   PubMed Web of Science ®Google Scholar
• Martinez-Vicente M, Sovak G, Cuervo AM. Protein degradation and aging. Exp Gerontol. 2005;40(8–9):622–633.
   PubMed Web of Science ®Google Scholar
• Pandey UB, Nie Z, Batlevi Y, et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature. 2007;447(7146):859–863.
   PubMed Web of Science ®Google Scholar
• Ji CH, Kwon YT. Crosstalk and interplay between the ubiquitin-proteasome system and autophagy. Mol Cells. 2017;40(7):441–449.
   PubMed Web of Science ®Google Scholar
• Yoo YD, Mun SR, Ji CH, et al. N-terminal arginylation generates a bimodal degron that modulates autophagic proteolysis. Proc Natl Acad Sci USA. 2018.
   PubMed Web of Science ®Google Scholar
• Das R, Melo JA, Thondamal M, et al. The homeodomain-interacting protein kinase HPK-1 preserves protein homeostasis and longevity through master regulatory control of the HSF-1 chaperone network and TORC1-restricted autophagy in Caenorhabditis elegans. PLoS Genetics. 2017;13(10):e1007038.
   PubMed Web of Science ®Google Scholar
• Finkel T. The metabolic regulation of aging. Nat Med. 2015;21(12):1416–1423.
   PubMed Web of Science ®Google Scholar
• Kim J, Kundu M, Viollet B, et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13(2):132–141.
   PubMed Web of Science ®Google Scholar
• Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2017.
   PubMed Web of Science ®Google Scholar
• Liu H, Zhang Y, Wu H, et al. Beneficial role of erythrocyte adenosine A2B receptor-mediated AMP-activated protein kinase activation in high-altitude hypoxia. Circulation. 2016;134(5):405–421.
   PubMed Web of Science ®Google Scholar
• Burkewitz K, Zhang Y, Mair WB. AMPK at the nexus of energetics and aging. Cell Metab. 2014;20(1):10–25.
   PubMed Web of Science ®Google Scholar
• Kennedy BK, Lamming DW. The mechanistic target of rapamycin: the grand conducTOR of metabolism and aging. Cell Metab. 2016;23(6):990–1003.
   PubMed Web of Science ®Google Scholar
• Cavalli G, Justice JN, Boyle KE, et al. Interleukin 37 reverses the metabolic cost of inflammation, increases oxidative respiration, and improves exercise tolerance. Proc Natl Acad Sci USA. 2017;114(9):2313–2318.
   PubMed Web of Science ®Google Scholar
• Kusano T, Yamaguchi K, Berberich T, et al. Advances in polyamine research in 2007. J Plant Res. 2007;120(3):345–350.
   PubMed Web of Science ®Google Scholar
• Eisenberg T, Knauer H, Schauer A, et al. Induction of autophagy by spermidine promotes longevity. Nat Cell Biol. 2009;11(11):1305–1314.
   PubMed Web of Science ®Google Scholar
• Minois N, Carmona-Gutierrez D, Madeo F. Polyamines in aging and disease. Aging (Albany NY). 2011;3(8):716–732.
   PubMedGoogle Scholar
• Gupta VK, Scheunemann L, Eisenberg T, et al. Restoring polyamines protects from age-induced memory impairment in an autophagy-dependent manner. Nat Neurosci. 2013;16(10):1453–1460.
   PubMed Web of Science ®Google Scholar
• Casero RA Jr., Marton LJ. Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat Rev Drug Discov. 2007;6(5):373–390.
   PubMed Web of Science ®Google Scholar
• Atiya Ali M, Poortvliet E, Stromberg R, et al. Polyamines in foods: development of a food database. Food Nutr Res. 2011;55. doi: 10.3402/fnr.v55i0.5572.
   Web of Science ®Google Scholar
• Ng F, Tang BL. Sirtuins’ modulation of autophagy. J Cell Physiol. 2013;228(12):2262–2270.
   PubMed Web of Science ®Google Scholar
• Canto C, Menzies KJ, Auwerx J. NAD(+) metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metab. 2015;22(1):31–53.
   PubMed Web of Science ®Google Scholar
• Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014;24(8):464–471.
   PubMed Web of Science ®Google Scholar
• van der Goot AT, Nollen EA. Tryptophan metabolism: entering the field of aging and age-related pathologies. Trends Mol Med. 2013;19(6):336–344.
   PubMed Web of Science ®Google Scholar
• Ma S, Yim SH, Lee SG, et al. Organization of the mammalian metabolome according to organ function, lineage specialization, and longevity. Cell Metab. 2015;22(2):332–343.
   PubMed Web of Science ®Google Scholar
• Rampelli S, Candela M, Turroni S, et al. Functional metagenomic profiling of intestinal microbiome in extreme ageing. Aging. 2013;5(12):902–912.
   PubMedGoogle Scholar
• Franceschi C, Bonafe M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244–254.
   PubMed Web of Science ®Google Scholar
• Franceschi C, Garagnani P, Vitale G, et al. Inflammaging and ‘Garb-aging’. Trends Endocrinol Metab. 2017;28(3):199–212.
   PubMed Web of Science ®Google Scholar
• Cuervo A, Wong E. Chaperone-mediated autophagy: roles in disease and aging. Cell Res. 2014;24(1):92–104.
   PubMed Web of Science ®Google Scholar
• Chondrogianni N, Gonos ES. Proteasome function determines cellular homeostasis and the rate of aging. Adv Exp Med Biol. 2010;694:38–46.
   PubMed Web of Science ®Google Scholar
• Giunta B, Fernandez F, Nikolic WV, et al. Inflammaging as a prodrome to Alzheimer’s disease. J Neuroinflammation. 2008;5:51.
   PubMed Web of Science ®Google Scholar
• Boren E, Gershwin ME. Inflamm-aging: autoimmunity, and the immune-risk phenotype. Autoimmun Rev. 2004;3(5):401–406.
   PubMed Web of Science ®Google Scholar
• Prattichizzo F, De Nigris V, La Sala L, et al. “Inflammaging” as a druggable target: a senescence-associated secretory phenotype-centered view of type 2 diabetes. Oxid Med Cell Longev. 2016;2016:1810327.
   PubMedGoogle Scholar
• Lencel P, Magne D. Inflammaging: the driving force in osteoporosis? Med Hypotheses. 2011;76(3):317–321.
   PubMed Web of Science ®Google Scholar
• Henry CJ, Marusyk A, DeGregori J. Aging-associated changes in hematopoiesis and leukemogenesis: what’s the connection? Aging. 2011;3(6):643–656.
   PubMedGoogle Scholar
• Henry CJ, Casás-Selves M, Kim J, et al. Aging-associated inflammation promotes selection for adaptive oncogenic events in B cell progenitors. J Clin Invest. 2015;125(12):4666–4680.
   PubMed Web of Science ®Google Scholar
• Nemkov T, Hansen KC, D’Alessandro A. A three-minute method for high-throughput quantitative metabolomics and quantitative tracing experiments of central carbon and nitrogen pathways. Rapid Commun Mass Spectrom. 2017;31(8):663–673.
   PubMed Web of Science ®Google Scholar
• Labzin LI, Heneka MT, Latz E. Innate immunity and neurodegeneration. Annu Rev Med. 2018;69:437-449.
   Google Scholar
• Iannaccone M, Titta F, Serretiello E, et al. Possible physiopathological effects of the transglutaminase activity on the molecular mechanisms responsible for human neurodegenerative diseases. Recent Pat CNS Drug Discov. 2014;9(2):76–84.
   PubMedGoogle Scholar
• Reddy PH, Beal MF. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer’s disease. Trends Mol Med. 2008;14(2):45–53.
   PubMed Web of Science ®Google Scholar
• Poon HF, Farr SA, Thongboonkerd V, et al. Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: implications for aging and age-related neurodegenerative disorders. Neurochem Int. 2005;46(2):159–168.
   PubMed Web of Science ®Google Scholar
• Penke B, Bogar F, Fulop L. beta-Amyloid and the pathomechanisms of Alzheimer’s disease: a comprehensive view. Molecules. 2017;22:10.
   Web of Science ®Google Scholar
• Muller UC, Deller T, Korte M. Not just amyloid: physiological functions of the amyloid precursor protein family. Nat Rev Neurosci. 2017;18(5):281–298.
   PubMed Web of Science ®Google Scholar
• Mockett BG, Richter M, Abraham WC, et al. Therapeutic potential of secreted amyloid precursor protein APPsalpha. Front Mol Neurosci. 2017;10:30.
   PubMed Web of Science ®Google Scholar
• Hefter D, Draguhn A. APP as a protective factor in acute neuronal insults. Front Mol Neurosci. 2017;10:22.
   PubMed Web of Science ®Google Scholar
• Manczak M, Kandimalla R, Yin X, et al. Hippocampal mutant APP and amyloid beta induced cognitive decline, dendritic spine loss, defective autophagy, mitophagy and mitochondrial abnormalities in a mouse model of Alzheimer’s disease. Hum Mol Genet. 2018.
   Web of Science ®Google Scholar
• Friedrich RP, Tepper K, Ronicke R, et al. Mechanism of amyloid plaque formation suggests an intracellular basis of Abeta pathogenicity. Proc Natl Acad Sci USA. 2010;107(5):1942–1947.
   PubMed Web of Science ®Google Scholar
• Manzoni C, Colombo L, Bigini P, et al. The molecular assembly of amyloid abeta controls its neurotoxicity and binding to cellular proteins. PLoS One. 2011;6(9):e24909.
   PubMed Web of Science ®Google Scholar
• Penke B, Toth AM, Foldi I, et al. Intraneuronal beta-amyloid and its interactions with proteins and subcellular organelles. Electrophoresis. 2012;33(24):3608–3616.
   PubMed Web of Science ®Google Scholar
• Cheignon C, Tomas M, Bonnefont-Rousselot D, et al. Oxidative stress and the amyloid beta peptide in Alzheimer’s disease. Redox Biol. 2017;14:450–464.
   PubMed Web of Science ®Google Scholar
• Volgyi K, Haden K, Kis V, et al. Mitochondrial proteome changes correlating with beta-amyloid accumulation. Mol Neurobiol. 2017;54(3):2060–2078.
   PubMed Web of Science ®Google Scholar
• Lai CS, Preisler J, Baum L, et al. Low molecular weight Abeta induces collapse of endoplasmic reticulum. Mol Cell Neurosci. 2009;41(1):32–43.
   PubMed Web of Science ®Google Scholar
• Luo J, Warmlander SK, Graslund A, et al. Cross-interactions between the Alzheimer disease amyloid-beta peptide and other amyloid proteins: a further aspect of the amyloid cascade hypothesis. J Biol Chem. 2016;291(32):16485–16493.
   PubMed Web of Science ®Google Scholar
• Groh N, Buhler A, Huang C, et al. Age-dependent protein aggregation initiates amyloid-beta aggregation. Front Aging Neurosci. 2017;9:138.
   PubMed Web of Science ®Google Scholar
• Nixon RA. The role of autophagy in neurodegenerative disease. Nat Med. 2013;19(8):983–997.
   PubMed Web of Science ®Google Scholar
• Boland B, Kumar A, Lee S, et al. Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer’s disease. J Neurosci. 2008;28(27):6926–6937.
   PubMed Web of Science ®Google Scholar
• Wolfe DM, Lee JH, Kumar A, et al. Autophagy failure in Alzheimer’s disease and the role of defective lysosomal acidification. Eur J Neurosci. 2013;37(12):1949–1961.
   PubMed Web of Science ®Google Scholar
• Safra M, Ben-Hamo S, Kenyon C, et al. The ire-1 ER stress-response pathway is required for normal secretory-protein metabolism in C. elegans. J Cell Sci. 2013;126(Pt 18):4136–4146.
   PubMed Web of Science ®Google Scholar
• Ohta K, Mizuno A, Li S, et al. Endoplasmic reticulum stress enhances gamma-secretase activity. Biochem Biophys Res Commun. 2011;416(3–4):362–366.
   PubMed Web of Science ®Google Scholar
• Rahman S, Archana A, Jan AT, et al. Dissecting endoplasmic reticulum unfolded protein response (UPR(ER)) in managing clandestine modus operandi of Alzheimer’s disease. Front Aging Neurosci. 2018;10:30.
   PubMed Web of Science ®Google Scholar
• Martin-Maestro P, Gargini R, Garcia E, et al. Slower dynamics and aged mitochondria in sporadic Alzheimer’s disease. Oxid Med Cell Longev. 2017;2017:9302761.
   PubMed Web of Science ®Google Scholar
• Kiko T, Nakagawa K, Satoh A, et al. Amyloid β levels in human red blood cells. PLoS One. 2012;7(11):e49620.
   PubMed Web of Science ®Google Scholar
• Kaminsky Y, Poghosyan A, Tikhonova L, et al. Glycolytic and proteolytic metabolism in erythrocytes from elderly and demented patients. Am J Neuroprot Neuroregen. 2012;4(1):73–77.
   Google Scholar
• Kosenko EA, Aliev G, Tikhonova LA, et al. Antioxidant status and energy state of erythrocytes in Alzheimer dementia: probing for markers. CNS Neurol Disord Drug Targets. 2012;11(7):926–932.
   PubMed Web of Science ®Google Scholar
• Kaminsky YG, Reddy VP, Ashraf GM, et al. Age-related defects in erythrocyte 2,3-diphosphoglycerate metabolism in dementia. Aging Dis. 2013;4(5):244–255.
   PubMed Web of Science ®Google Scholar
• Aliev G, Palacios HH, Walrafen B, et al. Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease. Int J Biochem Cell Biol. 2009;41(10):1989–2004.
   PubMed Web of Science ®Google Scholar
• Cenini G, Dowling AL, Beckett TL, et al. Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome. Biochim Biophys Acta. 2012;1822(2):130–138.
   PubMed Web of Science ®Google Scholar
• Nistor M, Don M, Parekh M, et al. Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain. Neurobiol Aging. 2007;28(10):1493–1506.
   PubMed Web of Science ®Google Scholar
• Webb RL, Murphy MP. beta-Secretases, Alzheimer’s disease, and Down syndrome. Curr Gerontol Geriatr Res. 2012;2012:362839.
   PubMedGoogle Scholar
• Head E, Helman A, Powell D, et al. Down syndrome, beta-amyloid and neuroimaging. Free Radic Biol Med. 2018;114:102-109.
   Google Scholar
• Jenkins EC, Marchi EJ, Velinov MT, et al. Longitudinal telomere shortening and early Alzheimer’s disease progression in adults with down syndrome. Am J Med Genet B Neuropsychiatr Genet. 2017;174(8):772-778.
   Google Scholar
• Aivazidis S, Coughlan C, Rauniyar A, et al. The burden of trisomy 21 disrupts the proteostasis network in Down syndrome. PLoS One. 2017;12(4):e0176307.
   PubMed Web of Science ®Google Scholar
• Perluigi M, Di Domenico F, Buttterfield DA. Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: insights from proteomics. Proteomics Clin Appl. 2014;8(1–2):73–85.
   PubMed Web of Science ®Google Scholar
• Di Domenico F, Coccia R, Cocciolo A, et al. Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer’s disease neuropathology: redox proteomics analysis of human brain. Biochim Biophys Acta Molecular Basis Disease. 2013;1832(8):1249–1259.
   PubMed Web of Science ®Google Scholar
• Freer R, Sormanni P, Vecchi G, et al. A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimer’s disease. Sci Adv. 2016;2(8):e1600947.
   PubMed Web of Science ®Google Scholar
• Mao F, Wang H, Ni W, et al. Design, synthesis, and biological evaluation of orally available first-generation dual-target selective inhibitors of acetylcholinesterase (AChE) and phosphodiesterase 5 (PDE5) for the treatment of Alzheimer’s Disease. ACS Chem Neurosci. 2018;9(2):328-345.
   Google Scholar
• Terry AV Jr, Buccafusco JJ. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J Pharmacol Exp Ther. 2003 Sep;306(3):821–827.
   Google Scholar
• Takahashi-Ito K, Makino M, Okado K, et al. Memantine inhibits beta-amyloid aggregation and disassembles preformed beta-amyloid aggregates. Biochem Biophys Res Commun. 2017;493(1):158–163.
   PubMed Web of Science ®Google Scholar
• Bo H, Kang W, Jiang N, et al. Exercise-induced neuroprotection of hippocampus in APP/PS1 transgenic mice via upregulation of mitochondrial 8-oxoguanine DNA glycosylase. Oxid Med Cell Longev. 2014;2014:834502.
   PubMedGoogle Scholar
• Guo JW, Guan PP, Ding WY, et al. Erythrocyte membrane-encapsulated celecoxib improves the cognitive decline of Alzheimer’s disease by concurrently inducing neurogenesis and reducing apoptosis in APP/PS1 transgenic mice. Biomaterials. 2017;145:106–127.
   PubMed Web of Science ®Google Scholar
• Agholme L, Clarin M, Gkanatsiou E, et al. Low-dose gamma-secretase inhibition increases secretion of Abeta peptides and intracellular oligomeric Abeta. Mol Cell Neurosci. 2017.pii: S1552-5260(17)33719-6.
   PubMed Web of Science ®Google Scholar
• Pringsheim T, Jette N, Frolkis A, et al. The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord. 2014;29(13):1583–1590.
   PubMed Web of Science ®Google Scholar
• Ascherio A, Schwarzschild MA. The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol. 2016;15(12):1257–1272.
   PubMed Web of Science ®Google Scholar
• Clark LN, Wang Y, Karlins E, et al. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology. 2006;67(10):1786–1791.
   PubMed Web of Science ®Google Scholar
• Lopez de Maturana R, Lang V, Zubiarrain A, et al. Mutations in LRRK2 impair NF-kappaB pathway in iPSC-derived neurons. J Neuroinflammation. 2016;13(1):295.
   PubMedGoogle Scholar
• Bonifati V, Rizzu P, van Baren MJ, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science. 2003;299(5604):256–259.
   PubMed Web of Science ®Google Scholar
• Nash Y, Schmukler E, Trudler D, et al. DJ-1 deficiency impairs autophagy and reduces alpha-synuclein phagocytosis by microglia. J Neurochem. 2017;143(5):584-594.
   Google Scholar
• Mastroberardino PG, Hoffman EK, Horowitz MP, et al. A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson’s disease. Neurobiol Dis. 2009;34(3):417–431.
   PubMed Web of Science ®Google Scholar
• Xiao B, Deng X, Lim GGY, et al. Superoxide drives progression of Parkin/PINK1-dependent mitophagy following translocation of Parkin to mitochondria. Cell Death Dis. 2017;8(10):e3097.
   PubMedGoogle Scholar
• Xiao B, Goh JY, Xiao L, et al. Reactive oxygen species trigger Parkin/PINK1 pathway-dependent mitophagy by inducing mitochondrial recruitment of Parkin. J Biol Chem. 2017;292(40):16697–16708.
   PubMed Web of Science ®Google Scholar
• Barodia SK, Creed RB, Goldberg MS. Parkin and PINK1 functions in oxidative stress and neurodegeneration. Brain Res Bull. 2017;133:51–59.
   PubMed Web of Science ®Google Scholar
• Xilouri M, Brekk OR, Stefanis L. alpha-Synuclein and protein degradation systems: a reciprocal relationship. Mol Neurobiol. 2013;47(2):537–551.
   PubMed Web of Science ®Google Scholar
• Chu Y, Dodiya H, Aebischer P, et al. Alterations in lysosomal and proteasomal markers in Parkinson’s disease: relationship to alpha-synuclein inclusions. Neurobiol Dis. 2009;35(3):385–398.
   PubMed Web of Science ®Google Scholar
• Sidransky E, Nalls MA, Aasly JO, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson’s disease. N Engl J Med. 2009;361(17):1651–1661.
   PubMed Web of Science ®Google Scholar
• Fernandes HJ, Hartfield EM, Christian HC, et al. ER stress and autophagic perturbations lead to elevated extracellular alpha-synuclein in GBA-N370S Parkinson’s iPSC-derived dopamine neurons. Stem Cell Rep. 2016;6(3):342–356.
   PubMed Web of Science ®Google Scholar
• Colla E, Coune P, Liu Y, et al. Endoplasmic reticulum stress is important for the manifestations of alpha-synucleinopathy in vivo. J Neurosci. 2012;32(10):3306–3320.
   PubMed Web of Science ®Google Scholar
• Colla E, Jensen PH, Pletnikova O, et al. Accumulation of toxic alpha-synuclein oligomer within endoplasmic reticulum occurs in alpha-synucleinopathy in vivo. J Neurosci. 2012;32(10):3301–3305.
   PubMed Web of Science ®Google Scholar
• Schapira AH. Mitochondrial dysfunction in Parkinson’s disease. Cell Death Differ. 2007;14(7):1261–1266.
   PubMed Web of Science ®Google Scholar
• Bose A, Beal MF. Mitochondrial dysfunction in Parkinson’s disease. J Neurochem. 2016;139(Suppl 1):216–231.
   PubMed Web of Science ®Google Scholar
• Martinez BA, Petersen DA, Gaeta AL, et al. Dysregulation of the mitochondrial unfolded protein response induces non-apoptotic dopaminergic neurodegeneration in C. elegans models of Parkinson’s disease. J Neurosci. 2017. ahead of print.
   Web of Science ®Google Scholar
• Poewe W, Seppi K, Tanner CM, et al. Parkinson disease. Nat Rev Dis Primers. 2017;3:17013.
   PubMed Web of Science ®Google Scholar
• Zhou W, Bercury K, Cummiskey J, et al. Phenylbutyrate up-regulates the DJ-1 protein and protects neurons in cell culture and in animal models of Parkinson disease. J Biol Chem. 2011;286(17):14941–14951.
   PubMed Web of Science ®Google Scholar
• Athauda D, Maclagan K, Skene SS, et al. Exenatide once weekly versus placebo in Parkinson’s disease: a randomised, double-blind, placebo-controlled trial. Lancet. 2017;390:1664–1675.
   PubMed Web of Science ®Google Scholar
• Milanese C, Tapias V, Gabriels S, et al. Mitochondrial complex I reversible S-nitrosation improves bioenergetics and is protective in Parkinson’s diseaseAntioxid Redox Signal. 2018 Jan 1;28(1):44–61.
   Google Scholar
• Skibinski G, Hwang V, Ando DM, et al. Nrf2 mitigates LRRK2- and alpha-synuclein-induced neurodegeneration by modulating proteostasis. Proc Natl Acad Sci USA. 2017;114(5):1165–1170.
   PubMed Web of Science ®Google Scholar
• Friesen EL, De Snoo ML, Rajendran L, et al. Chaperone-based therapies for disease modification in Parkinson’s disease. Parkinsons Dis. 2017;2017:5015307.
   PubMedGoogle Scholar
• Montojo MT, Aganzo M, Gonzalez N. Huntington’s disease and diabetes: chronological sequence of its association. J Huntingtons Dis. 2017;6(3):179–188.
   PubMed Web of Science ®Google Scholar
• Pearl JR, Heath LM, Bergey DE, et al. Enhanced retinal responses in Huntington’s disease patients. J Huntingtons Dis. 2017;6(3):237–247.
   PubMed Web of Science ®Google Scholar
• Rub U, Vonsattel JP, Heinsen H, et al. The neuropathology of Huntington’s disease: classical findings, recent developments and correlation to functional neuroanatomy. Adv Anat Embryol Cell Biol. 2015;217:1–146.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Kikuchi S, Katada S, et al. Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic. Hum Mol Genet. 2008;17(3):345–356.
   PubMed Web of Science ®Google Scholar
• Leitman J, Ulrich Hartl F, Lederkremer GZ. Soluble forms of polyQ-expanded huntingtin rather than large aggregates cause endoplasmic reticulum stress. Nat Commun. 2013;4:2753.
   PubMed Web of Science ®Google Scholar
• Wang B, Zeng L, Merillat SA, et al. The ubiquitin conjugating enzyme Ube2W regulates solubility of the Huntington’s disease protein, huntingtin. Neurobiol Dis. 2017;109(Pt A):127–136.
   PubMedGoogle Scholar
• Davies SW, Turmaine M, Cozens BA, et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell. 1997;90(3):537–548.
   PubMed Web of Science ®Google Scholar
• He WT, Xue W, Gao YG, et al. HSP90 recognizes the N-terminus of huntingtin involved in regulation of huntingtin aggregation by USP19. Sci Rep. 2017;7(1):14797.
   PubMedGoogle Scholar
• Koyuncu S, Fatima A, Gutierrez-Garcia R, et al. Proteostasis of huntingtin in health and disease. Int J Mol Sci. 2017;18:7.
   Web of Science ®Google Scholar
• Zhou H, Cao F, Wang Z, et al. Huntingtin forms toxic NH2-terminal fragment complexes that are promoted by the age-dependent decrease in proteasome activity. J Cell Biol. 2003;163(1):109–118.
   PubMed Web of Science ®Google Scholar
• Neueder A, Gipson TA, Batterton S, et al. HSF1-dependent and -independent regulation of the mammalian in vivo heat shock response and its impairment in Huntington’s disease mouse models. Sci Rep. 2017;7(1):12556.
   PubMedGoogle Scholar
• Finkbeiner S, Mitra S. The ubiquitin-proteasome pathway in Huntington’s disease. Sci World J. 2008;8:421–433.
   Google Scholar
• Prime ME, Andersen OA, Barker JJ, et al. Discovery and structure-activity relationship of potent and selective covalent inhibitors of transglutaminase 2 for Huntington’s disease. J Med Chem. 2012;55(3):1021–1046.
   PubMed Web of Science ®Google Scholar
• Colpo GD, Stimming EF, Rocha NP, et al. Promises and pitfalls of immune-based strategies for Huntington’s disease. Neural Regen Res. 2017;12(9):1422–1425.
   PubMed Web of Science ®Google Scholar
• Henning RH, Brundel B. Proteostasis in cardiac health and disease. Nat Rev Cardiol. 2017;14(11):637–653.
   PubMed Web of Science ®Google Scholar
• Lopaschuk GD, Spafford MA, Marsh DR. Glycolysis is predominant source of myocardial ATP production immediately after birth. Am J Physiol. 1991;261(6 Pt 2):H1698–1705.
   PubMedGoogle Scholar
• Gong G, Song M, Csordas G, et al. Parkin-mediated mitophagy directs perinatal cardiac metabolic maturation in mice. Science. 2015;350(6265):aad2459.
   PubMed Web of Science ®Google Scholar
• Shi R, Guberman M, Kirshenbaum LA. Mitochondrial quality control: the role of mitophagy in aging. Trends Cardiovasc Med. 2017. pii: S1050-1738(17)30180-9. doi: 10.1016/j.tcm.2017.11.008.
   PubMedGoogle Scholar
• Billia F, Hauck L, Konecny F, et al. PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function. Proc Natl Acad Sci USA. 2011;108(23):9572–9577.
   PubMed Web of Science ®Google Scholar
• Dorn GW 2nd. Parkin-dependent mitophagy in the heart. J Mol Cell Cardiol. 2016;95:42–49.
   PubMed Web of Science ®Google Scholar
• Bravo-San Pedro JM, Kroemer G, Galluzzi L. Autophagy and mitophagy in cardiovascular disease. Circ Res. 2017;120(11):1812–1824.
   PubMed Web of Science ®Google Scholar
• Rainer PP, Dong P, Sorge M, et al. Desmin phosphorylation triggers preamyloid oligomers formation and myocyte dysfunction in acquired heart failure. Circ Res. 2018.
   PubMedGoogle Scholar
• Agnetti G, Halperin VL, Kirk JA, et al. Desmin modifications associate with amyloid-like oligomers deposition in heart failure. Cardiovasc Res. 2014;102(1):24–34.
   PubMed Web of Science ®Google Scholar
• Johnson TD, Hill RC, Dzieciatkowska M, et al. Quantification of decellularized human myocardial matrix: a comparison of six patients. Proteomics-Clinical Appl. 2016;10(1):75–83.
   PubMed Web of Science ®Google Scholar
• Laklai H, Miroshnikova YA, Pickup MW, et al. Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression. Nat Med. 2016;22(5):497–505.
   PubMed Web of Science ®Google Scholar
• Calle EA, Hill RC, Leiby KL, et al. Targeted proteomics effectively quantifies differences between native lung and detergent-decellularized lung extracellular matrices. Acta Biomaterialia. 2016;46:91–100.
   PubMed Web of Science ®Google Scholar
• Balch WE, Sznajder JI, Budinger S, et al. Malfolded protein structure and proteostasis in lung diseases. Am J Respir Crit Care Med. 2014;189(1):96–103.
   PubMed Web of Science ®Google Scholar
• King P, Tulloh R. Management of pulmonary hypertension and Down syndrome. Int J Clin Pract Suppl. 2011;174:8–13.
   Google Scholar
• Clark AR, Lubsen NH, Slingsby C. sHSP in the eye lens: crystallin mutations, cataract and proteostasis. Int J Biochem Cell Biol. 2012;44(10):1687–1697.
   PubMed Web of Science ®Google Scholar
• Bassnett S. On the mechanism of organelle degradation in the vertebrate lens. Exp Eye Res. 2009;88(2):133–139.
   PubMed Web of Science ®Google Scholar
• Peschek J, Braun N, Rohrberg J, et al. Regulated structural transitions unleash the chaperone activity of alphaB-crystallin. Proc Natl Acad Sci USA. 2013;110(40):E3780–3789.
   PubMed Web of Science ®Google Scholar
• Surguchev A, Surguchov A. Conformational diseases: looking into the eyes. Brain Res Bull. 2010;81(1):12–24.
   PubMed Web of Science ®Google Scholar
• Thornell E, Aquilina A. Regulation of alphaA- and alphaB-crystallins via phosphorylation in cellular homeostasis. Cell Mol Life Sci. 2015;72(21):4127–4137.
   PubMed Web of Science ®Google Scholar
• Tang HZ, Yang LM. Activation of the unfolded protein response in aged human lenses. Mol Med Rep. 2015;12(1):389–393.
   PubMed Web of Science ®Google Scholar
• Rappa F, Farina F, Zummo G, et al. HSP-molecular chaperones in cancer biogenesis and tumor therapy: an overview. Anticancer Res. 2012;32(12):5139–5150.
   PubMed Web of Science ®Google Scholar
• Blackburn EH, Epel ES, Lin J. Human telomere biology: a contributory and interactive factor in aging, disease risks, and protection. Science. 2015;350(6265):1193–1198.
   PubMed Web of Science ®Google Scholar
• Alasiri G, Fan LY, Zona S, et al. ER stress and cancer: the FOXO forkhead transcription factor link. Mol Cell Endocrinol. 2018;462(Pt B):67-81.
   Google Scholar
• Xu S, Sankar S, Neamati N. Protein disulfide isomerase: a promising target for cancer therapy. Drug Discov Today. 2014;19(3):222–240.
   PubMed Web of Science ®Google Scholar
• White E. The role for autophagy in cancer. J Clin Invest. 2015;125(1):42–46.
   PubMed Web of Science ®Google Scholar
• Myatt SS, Lam EW. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 2007;7(11):847–859.
   PubMed Web of Science ®Google Scholar
• Sklirou A, Papanagnou ED, Fokialakis N, et al. Cancer chemoprevention via activation of proteostatic modules. Cancer Lett. 2018;413:110-121.
   Google Scholar
• Kwak MK, Wakabayashi N, Greenlaw JL, et al. Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway. Mol Cell Biol. 2003;23(23):8786–8794.
   PubMed Web of Science ®Google Scholar
• Devisscher L, Vieri M, Logue SE, et al. Targeting the angio-proteostasis network: combining the forces against cancer. Pharmacol Ther. 2016;167:1–12.
   PubMed Web of Science ®Google Scholar
• De Smet F, Saiz Rubio M, Hompes D, et al. Nuclear inclusion bodies of mutant and wild-type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregation. J Pathol. 2017;242(1):24–38.
   PubMed Web of Science ®Google Scholar
• Maneix L, Catic A. Touch and go: nuclear proteolysis in the regulation of metabolic genes and cancer. FEBS Lett. 2016;590(7):908–923.
   PubMed Web of Science ®Google Scholar
• D’Alessandro A, Amelio I, Berkers CR, et al. Metabolic effect of TAp63α: enhanced glycolysis and pentose phosphate pathway, resulting in increased antioxidant defense. Oncotarget. 2014;5(17):7722–7733.
   PubMedGoogle Scholar
• Cheng Q, Chen J. Mechanism of p53 stabilization by ATM after DNA damage. Cell Cycle. 2010;9(3):472–478.
   PubMed Web of Science ®Google Scholar
• Gregory MA, D’Alessandro A, Alvarez-Calderon F, et al. ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia. Proc Natl Acad Sci USA. 2016;113(43):E6669–E6678.
   PubMed Web of Science ®Google Scholar
• Polubotko EA, Smirnova NV, Pleskach NM, et al. Premature aging syndrome in ataxia telangiectasia patients. Cell Tissue Biol. 2009;3(5):491.
   Google Scholar
• Poletto M, Yang D, Fletcher SC, et al. Modulation of proteostasis counteracts oxidative stress and affects DNA base excision repair capacity in ATM-deficient cells. Nucleic Acids Res. 2017;45(17):10042–10055.
   PubMed Web of Science ®Google Scholar
• Bonvini P, Zorzi E, Basso G, et al. Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30+ anaplastic large cell lymphoma. Leukemia. 2007;21(4):838–842.
   PubMed Web of Science ®Google Scholar
• Lee DM, Kim IY, Seo MJ, et al. Nutlin-3 enhances the bortezomib sensitivity of p53-defective cancer cells by inducing paraptosis. Exp Mol Med. 2017;49(8):e365.
   PubMedGoogle Scholar
• Leu JI, Barnoud T, Zhang G, et al. Inhibition of stress-inducible HSP70 impairs mitochondrial proteostasis and function. Oncotarget. 2017;8(28):45656–45669.
   PubMedGoogle Scholar
• Li J, Yakushi T, Parlati F, et al. Capzimin is a potent and specific inhibitor of proteasome isopeptidase Rpn11. Nat Chem Biol. 2017;13(5):486–493.
   PubMed Web of Science ®Google Scholar
• Rodriguez KA, Valentine JM, Kramer DA, et al. Determinants of rodent longevity in the chaperone-protein degradation network. Cell Stress Chaperones. 2016;21(3):453–466.
   PubMed Web of Science ®Google Scholar
• Herndon LA, Schmeissner PJ, Dudaronek JM, et al. Stochastic and genetic factors influence tissue-specific decline in ageing C. elegans. Nature. 2002;419(6909):808.
   PubMed Web of Science ®Google Scholar
• Walther DM, Mann M. Accurate quantification of more than 4000 mouse tissue proteins reveals minimal proteome changes during aging. Mol Cell Proteomics. 2011;10(2):M110. 004523.
   PubMed Web of Science ®Google Scholar
• Grant JE, Bradshaw AD, Schwacke JH, et al. Quantification of protein expression changes in the aging left ventricle of Rattus norvegicus. J Proteome Res. 2009;8(9):4252.
   PubMed Web of Science ®Google Scholar
• Tsugita A, Kawakami T, Uchida T, et al. Proteome analysis of mouse brain: two‐dimensional electrophoresis profiles of tissue proteins during the course of aging. Electrophoresis. 2000;21(9):1853–1871.
   PubMed Web of Science ®Google Scholar
• Schiller HB, Fernandez IE, Burgstaller G, et al. Time‐and compartment‐resolved proteome profiling of the extracellular niche in lung injury and repair. Mol Syst Biol. 2015;11(7):819.
   PubMed Web of Science ®Google Scholar
• Schiller HB, Fernandez IE, Burgstaller G, et al. Quantitative proteomic profiling of extracellular matrix composition and protein secretion reveals novel modulators of pulmonary fibrosis, in B97. A Scar is Born: new insights in lung fibrogenesis. Am Thoracic Soc. 2014;A3652–A3652.
   Google Scholar
• Perluigi M, di Domenico F, Fiorini A, et al. Oxidative stress occurs early in Down syndrome pregnancy: a redox proteomics analysis of amniotic fluid. Proteomics Clin Appl. 2011;5(3‐4):167–178.
   PubMed Web of Science ®Google Scholar
• Eyre DR, Paz MA, Gallop PM. Cross-linking in collagen and elastin. Ann Rev Biochem. 1984;53(1):717–748.
   PubMedGoogle Scholar
• Haus JM, Carrithers JA, Trappe SW, et al. Collagen, cross-linking, and advanced glycation end products in aging human skeletal muscle. J Appl Physiol (1985). 2007;103(6):2068–2076.
   PubMed Web of Science ®Google Scholar
• Gkogkolou P, Bohm M. Advanced glycation end products: key players in skin aging? Dermatoendocrinol. 2012;4(3):259–270.
   PubMedGoogle Scholar
• Byun K, Yoo Y, Son M, et al. Advanced glycation end-products produced systemically and by macrophages: a common contributor to inflammation and degenerative diseases. Pharmacol Ther. 2017;177:44–55.
   PubMed Web of Science ®Google Scholar
• Barrett AS, Wither MJ, Hill RC, et al. Hydroxylamine chemical digestion for insoluble extracellular matrix characterization. J Proteome Res. 2017;16:4177–4184.
   PubMed Web of Science ®Google Scholar
• Goddard ET, Hill RC, Barrett A, et al. Quantitative extracellular matrix proteomics to study mammary and liver tissue microenvironments. Int J Biochem Cell Biol. 2016;81:223–232.
   PubMed Web of Science ®Google Scholar
• Hill RC, Wither MJ, Nemkov T, et al. Preserved proteins from extinct Bison latifrons identified by tandem mass spectrometry; hydroxylysine glycosides are a common feature of ancient collagen. Mol Cell Proteomics. 2015;14(7):1946–1958.
   PubMed Web of Science ®Google Scholar
• Buckwalter JA, Woo S, Goldberg V, et al. Soft-tissue aging and musculoskeletal function. J Bone Joint Surg Am. 1993;75(10):1533–1548.
   PubMedGoogle Scholar
• Verzijl N, DeGroot J, Ben ZC, et al. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis. Arthritis Rheum. 2002;46(1):114–123.
   PubMedGoogle Scholar
• Eyre D, Dickson I, Van Ness K. Collagen cross-linking in human bone and articular cartilage. Age-related changes in the content of mature hydroxypyridinium residues. Biochem J. 1988;252:495–500.
   PubMed Web of Science ®Google Scholar
• Koo EH, Park L, Selkoe DJ. Amyloid beta-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth. Proc Natl Acad Sci USA. 1993;90(10):4748–4752.
   PubMed Web of Science ®Google Scholar
• Klier FG, Cole G, Stallcup W, et al. Amyloid β-protein precursor is associated with extracellular matrix. Brain Res. 1990;515(1):336–342.
   PubMed Web of Science ®Google Scholar
• Tanford C, Reynolds J. Nature’s Robots: a history of proteins. New York: Oxford University Press; 2001.
   Google Scholar
• Asimov I. Runaround. In: Robot I. New York City: Doubleday; 1950.
   Google Scholar
• Culp-Hill R, Zheng C, Reisz JA, et al. Red blood cell metabolism in Down syndrome: hints on metabolic derangements in aging. Blood Adv. Forthcoming 2017.
   Web of Science ®Google Scholar
• Straat M, van Bruggen R, de Korte D, et al. Red blood cell clearance in inflammation. Transfus Med Hemother. 2012;39(5):353–361.
   PubMed Web of Science ®Google Scholar
• Pietras EM. Inflammation: a key regulator of hematopoietic stem cell fate in health and disease. Blood. 2017;130(15):1693–1698.
   PubMed Web of Science ®Google Scholar
• de Lustig ES, Serra JA, Kohan S, et al. Copper-zinc superoxide dismutase activity in red blood cells and serum in demented patients and in aging. J Neurol Sci. 1993;115(1):18–25.
   PubMed Web of Science ®Google Scholar
• Stockwell BR, Friedmann Angeli JP, Bayir H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171(2):273–285.
   PubMed Web of Science ®Google Scholar
• Tran BQ, Goodlett DR, Goo YA. Advances in protein complex analysis by chemical cross-linking coupled with mass spectrometry (CXMS) and bioinformatics. Biochim Biophys Acta Proteins Proteomics. 2016;1864(1):123–129.
   Web of Science ®Google Scholar
• Batth TS, Francavilla C, Olsen JV. Off-line high-pH reversed-phase fractionation for in-depth phosphoproteomics. J Proteome Res. 2014;13(12):6176–6186.
   PubMed Web of Science ®Google Scholar